References
Filters: Author is Rosenthal, P [Clear All Filters]
Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2020;71(1):31-43.
. Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2019;doi: 10.1002/hep.30821. [Epub ahead of print].
.